ognized form of pyruvate decaboxy lase (PDC) developed lactic acidosis, hyperammonemia, and proximal renal tubular acidosis, along wlth persistent ketosis and severe retardation of growth and development. Urine metabolites showed consistently high lactate, pyruvate, fumarate, and succinate, the latter two unusual in most forms of congenital lactic acidosis. Ornithine transcarbmyalase was demonstrated at 50% normal activity in the one patient measured. This may partially explain the persistent hyperammonemia. Therapy with megadoses of thiamine, pyridoxine. and monosodium glutamate were without effect. Large doses of biotin caused a transient decrease in the lactic acidosis but no long term clinical effect was demonstrated. Ketogenetic diet, often advocated for treatment of lactic acidosis, resulted in clinical deterioriation. Therapy wlth large doses of citrate, possibly acting as a TCA cycle substrate, resulted in cllnical stabilization but continued poor development. These two patients appear to represent a new variation of congenital lactic acidosis which have not responded to conventional forms of therapy. Acidic g&ohydrolases invo1ved.h the deg;adation of glycoprotein are present in smell amounts in normal urines, but :ncrease 4-fold in active renal diseases in children. To assess early renal involvement in JDM, Addis counts (timed urinary cell excretions), quantitative proteinuria, creatinine clearance, urinary acidic glycohydrolases. B-gslactosidase (B-galase), B-Nhexosaminidase (B-hexase), and plasma acidic glycohydrolases, 6-galactosidase, B-galase, B-hexase,o(-mannosidase (a-mannase), 6-fucosidase, wcre studied in 110 JDM children aged 3-16 years.
URINARY ACIDIC GLYCOHXDROLASE AS AN
Urinary B-galase and B-hexase was significantly higher in JDI4 than in normals, but lower than in children with actlve renal disease. Urinary B-gal.ase, B-hexase had no corr~lation to urinary RE'S, WBC's, protein and sugar, but significantly correlated to plasma trjglycerides, age of the child, end duration of JDM (p<0.01).
Of the plasma glycohydrolase, B-hexase and o(-mennnse correlated to blood sugar, cholesterol, tr5.glycerides anrl to age of the child and duration of JIM (~40.01). S5x hours after insulin, mean urinary B-calase and B-hexape in 1.8 children returned to n e w normal. 1.evels. These data suegest that both urinary and pln.ma acidic ~1.ycohydrolares may be used as an index of elyconrotein cntnbolism and hence eorly renul involvement in JIM. Activities of the active and inactive forms of pyruvate decarboxylase (PDC) were measured in fibroblasts from normal individuals and a patient with congenital lactic acidemia, utilizing 1% MgCl2 to acl.ivate the enzyme from sonicated fibroblasts. The activities of th.: active and inactive forms in the patient were 0.56 f 0.21 and 0.87 f 0.33 and in the controls 8.01 f 2.80 and 1.81 f 0.39 nmoles/mg protein/hr. In the patient, the active form accountwl for 39% of total PDC activity, while in the normals 77% of total PDC activity was present as the active form. The optimum pH (6.0) and Michaelis constants (Km) for pyruvate were similar in fibroblasts of the patient and controls. PDC activity was m-re sensitive to denaturation by heat in the fibroblasts of the patient than those from controls. Incubation for 5 minutes at 46.5'C led to a complete loss of activity in the patient, while there was still 25% of original activity in the controls. This difference in heat stability may be related to the difference in the ratio of active to inactive forms between the fibroblasts from controls and the patient. It suggests an altered molecular form of the enzyme protein as a result of a mutation in a structural gene. (5$,4~7, ages 12-17 yrs. ,were studied with paired Arginine infusion tests (AIT) after 12-hr. fasts, and 3 days of isocaloric diets. Followinp AIT-l,DPH(3mg/k?)was infused not to exceed 100 mg/min.Atter 20 min.,AIT-2 was done.Serial blood samples for BS and IRG were obtained over 300 min. IRG was measured by RIA using 30 K antisera and dextran-charcoal separation,with 95X confidence limits of f2h pg/ml.Mean pre-and post-UP11 BS increments were 75'13 and €7'13 mg/dl.Mean fasting pre-and post-DPH IRG were 174?34(MfSE)and 186f77.Mean pre-and post-DPH AIRG were 273'79 and 212f49.Vean X decrement in AIRG after DPH was 14.2fll.O(NS). Five pts. had 40.4f3.8 mean X decrement in AIRG post DPH. Absolute AIRG pre-and post-DPP in this group were 352'130 and 213t77(P> 0.05). Three randomly selected patients on btdaily Insulin therapy received 6 mos.DPH (5mglkglday). Single AIT were done at 0.5, and 180 days.Vean fasting IRG values were 140f33,122+24,175f57; mean AIRG values were 159'41,175f48.and 161'28 pg/ml,respectively. There wafi no significant statistic correlation between duration of JDM,age of pt.,or insulin therapy and DPH effect on arginineinduced IRG secretion.This study appears to be the first in vivo evaluation of DPH effects on alpha-cell function in JDFI suggesting some modification of arginine-induced IRG secretion. Uptake of glucose and release of gluconeogenic precursors by the hindlimb of the fasting baboon infant was evaluated in 6 baboon neonates after delivery by cesarean section at term and 8 6-week-old baboon infanta. Arteriovenoua (AV) differences across the hindlimb were determined by measuring substrate levels in the aorta and the inferior vena cava below the level of the renal veins and above a unilaterally occluded femoral vein.
UPTAKE OF GLUCOSE AND RELEASE OF GLUCONEOGENIC
Substrate hydroxybutyrate, glutamate or glutamine. Production and uptake was calculated using hindlimb blood flows determined by the radioactive microsphere method. Glucose consumption by the hindlimb in the neonate was 2.4 uM/min. Uptake by the entire carcass waa estimated to be 9.6 uM/min, almost twice the previously estimated cerebral cortex glucose consumption (5.6 uM/min). Estimated splanchnic and renal glucose production (15.7 pM/min) could account for all (15.2 uM/min) of estimated cerebral and carcass glucose uptake. The fasting neonate has a substantial glucose utilization rate exclusive of the requirement of the central nervous system.
